Case Form
Find Out if You Potentially Qualify for a Financial Reward by filling out the form.
Jefferies downgraded Medpace, citing perceived weaknesses in the Company’s business model as a contract research organization amid pressure on biotechnology funding.
Following this news, Medpace’s stock price fell over 9% on September 25, 2024.